Hanne Mørck Nielsen

Hanne Mørck Nielsen

PhD (Pharm) MSc (Pharm)

19962019

Research activity per year

Network

Else Marie Agger

  • Statens Serum Institut

External person

Else Marie Agger

  • Statens Serum Institut

External person

Peter Ifversen

  • Coloplast A/s

External person

Lene Jørgensen

  • Department of Drug Metabolism, H. Lundbeck A/S,

External person

Peter Andersen

  • Statens Serum Institut

External person

Ida Rosenkrands

  • Statens Serum Institut

External person

Dennis Christensen

  • Statens Serum Institut

External person

Martin Alm

  • BioModics ApS

External person

Giovanni M. Pavan

  • University of Applied Sciences of Southern Switzerland

External person

Flemming Madsen

  • Coloplast A/s

External person

S. Gehrig

  • University of Zurich

External person

Twan Lammers

  • Utrecht University

External person

Anne Sandberg-Schaal

  • Forskningsområdet, Sundhedsvidenskab

External person

Paul Robert Hansen

  • Kemi og Biokemi

External person

Saeid Koocheki

  • Razi University

External person

Jimena Fernandez-Carneado

  • Parc Cientific de Barcelona

External person

Karen Smith Korsholm

  • Statens Serum Institut

External person

Matthew Bunker

  • Molecular Profiles Ltd

External person

Andrea Danani

  • University of Applied Sciences of Southern Switzerland

External person

Helle M. Arboe-Andersen

  • Institut for farmaci og analytisk kemi

External person

Gert Storm

  • Utrecht University

External person

Anne Sandberg-Schaal

  • Forskningsområdet, Sundhedsvidenskab

External person

Martin Malmsten

  • Uppsala University

External person

Paul Whitside

  • Molecular Profiles Ltd

External person

K. Petersson

  • LEO-Pharma

External person

David Scurr

  • University of Nottingham

External person

Sandra Rutherford

  • Molecular Profiles Ltd

External person

Margaret Saunders

  • University Hospitals Bristol and Weston NHS Foundation Trust

External person

Koen Raemdonck

  • Ghent University

External person

Kim Lambertsen Larsen

  • Aalborg University

External person

Tommy Nylander

  • Dept. Chemistry, Univ. Lund

External person

Amir K Varkouhi

  • Utrecht University

External person

Mette E Skindersø

  • Statens Serum Institut

External person

Mladen Stojanov

  • Aalborg University

External person

Laura Cartwright

  • University Hospitals Bristol and Weston NHS Foundation Trust

External person

Broes Naeye

  • Ghent University

External person

Dan Stærk

  • Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen

External person

Anja Boisen

  • Department of Micro- and Nanotechnology, Technical University of Denmark
  • Technical University of Denmark
  • Danmarks Tekniske Universitet

External person

Ingrid Hausser

  • Universitäts-Hautklinik

External person

Raymond Schiffelers

  • Utrecht University

External person

Adrián Valázquez-Campoy

  • University of Zaragoza

External person

Ernest Giralt

  • Parc Cientific de Barcelona

External person

Rupa S. Appa

  • Novo Nordisk A/S (Biz)

External person

Søren Manniche

  • Nordic Vaccine A/S

External person

Reinhard Wimmer

  • Department of Chemistry and Bioscience, Section for Biotechnology, Aalborg University, Frederik Bajers Vej 7H, DK-9220 Aalborg, Denmark

External person

Johanna M. Brandner

  • University Hospital Hamburg-Eppendorf
  • University of Hamburg

External person

Flemming Jessen

  • Danmarks Tekniske Universitet

External person

Morten Jonas Maltesen

  • Novozymes Biopharma A/S

External person

Drissa Diallo

  • Institut National de Recherche en Santé Publique

External person

Yanhong Wen

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

External person

Pall Thor Ingvarsson

  • Statens Serum Institut

External person

Teis Esben Sondergaard

  • Department of Chemistry and Bioscience, Section for Biotechnology, Aalborg University, Frederik Bajers Vej 7H, DK-9220 Aalborg, Denmark

External person

Drissa Diallo

  • Departement de Medecine Traditionelle, School of Pharmacy

External person

Clare J. Strachan

  • University of Helsinki

External person

R. S. Appa

  • Novo Nordisk A/S (Biz)

External person

Shervin Bahrami

  • Aarhus Universitet

External person

Lars Hovgaard

  • Oral Formulation Development, Novo Nordisk A/S

External person

Chifundera Kusamba Zacharie

  • Department of Biology and Wildlife Resources Management, Faculty of Sciences, National Pedagogical University, Kinshasa

External person

Peter Andersen

  • Statens Serum Institut

External person

Johannes van Staden

  • University of KwaZulu-Natal

External person

Bernard C M Te Boekhorst

  • Eindhoven Universtiy of Technology

External person

Lars Linderoth

  • Novo Nordisk A/S (Biz)
  • Technical University of Denmark
  • Universidad de los Andes Colombia

External person

Daniel Kirby

  • Aston University

External person

Negin Rahanjam

  • University of British Columbia

External person

Martin Dufva

  • DTU Nanotech, Technical University of Denmark

External person

Hanne Everland

  • Coloplast A/s

External person

Mette Loftager

  • Novo Nordisk A/S (Biz)

External person

Brian S. Sproat

  • Chemconsilium GCV

External person

M. Malmsten

  • Uppsala University

External person

Richard A. Campbell

  • Institut Max Von Laue Paul Langevin

External person

Katrine Dragsbæk Madsen

  • Department of Pharmacy, University of Copenhagen

External person

Birgitte Hyrup

  • b Fertin Pharma A/S

External person

Jan Skov Pedersen

  • Aarhus University

External person

Megan Jones

  • Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.

External person

Lisbeth Grøndahl

  • University of Queeensland

External person

L. Zhang

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

External person

Elize Van Driessche

  • Ghent University

External person

D. M. Karpf

  • Novo Nordisk A/S (Biz)

External person

Erik Ilsø Christensen

  • Anatomisk Institut, Aarhus Universitet

External person

Wouter Leonardus Joseph Hinrichs

  • University of Groningen

External person

Frank Follmann

  • Statens Serum Institut

External person

Kinga Zor

  • Danmarks Tekniske Universitet

External person

Niklas Sandler

  • University of Otago

External person

Johannes Van Staden

  • Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg

External person

Long Zhang

  • University of Copenhagen

External person

Gustav J Strijkers

  • Eindhoven Universtiy of Technology

External person

Carina Vingsbo Lundberg

  • Statens Serum Institut

External person

Charlotte Vermehren

  • LiPlasome Pharma A/S

External person

Tayba Sajiid Khiljii

  • Institut for farmaci og analytisk kemi, FARMA

External person

Morten Allesø

  • H. Lundbeck A/S

External person

Nicolai Kirkby

  • Nordic Vaccine A/S

External person

T. N. Krogh

  • Novo Nordisk A/S (Biz)

External person

Isabell Vargas Christensen

  • Novo Nordisk A/S (Biz)
  • University of Copenhagen

External person

E. I. Christensen

  • Aarhus Universitet

External person

Raymond M Schiffelers

  • Utrecht University

External person

Monique Gangloff

  • University of Cambridge

External person

Fabrice Rose

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark.

External person

Noemi Rozlosnik

  • Department of Micro- and Nanotechnology, Technical University of Denmark

External person

Mechthild Schmitt

  • University of Helsinki

External person

Yvonne Perrie

  • Aston University

External person

Erik I. Christensen

  • Aarhus Universitet

External person

Maja H. Nielsen

  • Department of Pharmacy, University of Copenhagen

External person

Heinz-Georg Jahnke

  • Swiss Federal Institute of Technology

External person

Annette G. Beck-Sickinger

  • Institute of Biochemistry

External person

Giulio Pojana

  • University Ca' Foscari of Venice

External person

Rachel Tréhin

  • Swiss Federal Institute of Technology

External person

Y. A. Ioannou

  • Icahn School of Medicine at Mount Sinai

External person

Robert E W Hancock

  • University of British Columbia

External person

Ulrike Krauss

  • Swiss Federal Institute of Technology

External person

Daniel Pletzer

  • University of British Columbia

External person

Monica R. Gallego

  • Coloplast A/s

External person

Arto Urtti

  • University of Helsinki

External person

Ioannis S. Chronakis

  • Division of Industrial Food Research

External person

Amir K. Varkouhi

  • Utrecht University

External person

Niels Bent Larsen

  • Department of Micro- and Nanotechnology, DTU Nanotech, Technical University of Denmark

External person

Clive A. Prestidge

  • University of South Australia

External person

Klaas Nicolay

  • Eindhoven Universtiy of Technology

External person

Jeffrey L. Watts

  • Zoetis Inc.
  • Pfizer

External person

Stefaan C. de Smedt

  • Ghent University

External person

Cristiano Luis Pinto De Oliveira

  • Institut for Kemi, Aarhus Universitet
  • Institute of Physics

External person

Niels Frimodt-Møller

  • National Center for Antimicrobials and Infection Control

External person

Håvard Jenssen

  • Institut for Natur, Systemer og Modeller
  • Roskilde University

External person

Hans P Merkle

  • Swiss Federal Institute of Technology

External person

Noemi Rozlosnik

  • Danmarks Tekniske Universitet

External person

Claus-Michael Lehr

  • Helmholtz Institute for Pharmaceutical Research Saarland

External person